Literature DB >> 6156905

Induction of 2',5'-oligoadenylate synthetase and interferon in mouse trigeminal ganglia infected with herpes simplex virus.

Y Sokawa, T Ando, Y Ishihara.   

Abstract

The activity of 2',5'-oligoadenylate synthetase, which is induced by interferon action, was detected in mouse trigeminal ganglia infected with herpes simplex virus (HSV) type 1. When HSV was inoculated on the left cheek of mice, the virus began to appear in the ipsilateral trigeminal ganglia on day 2, reached its maximum accumulation on day 4, declined thereafter, and was no longer detected in the tissue homogenate after 11 days. After this short acute productive phase, the virus entered into the latent phase of infection. 2',5'-Oligoadenylate synthetase appeard in the trigeminal ganglia shortly after the beginning of virus multiplication; the synthetase activity began to rise on day 3, reached a maxium level on day 4, and then declined. Interferon activity (type I) also appeared in the infected ganglia, but diminished more rapidly than the synthetase. The antibody against HSV in the sera began to appear at the time when the virus and synthetase were declining. From these results it may be hypothesized, although not concluded, that in the acute productive phase of HSV infection in mouse trigeminal ganglia, virus multiplication is suppressed by interferon action, including 2',5'-oligoadenylate synthetase induction.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156905      PMCID: PMC551010          DOI: 10.1128/iai.28.3.719-723.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Latent infection of the peripheral ANS with herpes simplex virus.

Authors:  R W Price; B J Katz; A L Notkins
Journal:  Nature       Date:  1975-10-23       Impact factor: 49.962

2.  Production of interferon by immune lymphocytes exposed to herpes simplex virus-antibody complexes.

Authors:  T Fujibayashi; J J Hooks; A L Notkins
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

3.  Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection.

Authors:  J E Oakes
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

4.  Latent ganglionic infection with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy.

Authors:  M A Walz; R W Price; A L Notkins
Journal:  Science       Date:  1974-06-14       Impact factor: 47.728

5.  Latent infections induced by herpes simplex viruses.

Authors:  J G Stevens; M L Cook
Journal:  Cancer Res       Date:  1973-06       Impact factor: 12.701

6.  Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection.

Authors:  M L Cook; J G Stevens
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

7.  Latent herpes simplex virus in spinal ganglia of mice.

Authors:  J G Stevens; M L Cook
Journal:  Science       Date:  1971-08-27       Impact factor: 47.728

8.  Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells.

Authors:  A G Hovanessian; R E Brown; I M Kerr
Journal:  Nature       Date:  1977-08-11       Impact factor: 49.962

9.  Appearance of interferon inducibility and sensitivity during differentiation of murine teratocarcinoma cells in vitro.

Authors:  D C Burke; C F Graham; J M Lehman
Journal:  Cell       Date:  1978-02       Impact factor: 41.582

10.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses.

Authors:  I Gresser; M G Tovey; C Maury; M T Bandu
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  10 in total

1.  Herpes simplex virus, type 1 invasion of the rabbit and mouse nervous systems revealed by in situ hybridization.

Authors:  W G Stroop; D C Schaefer
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

2.  Serum 2'-5'oligoadenylate synthetase as a monitoring marker of anti-viral effect during interferon therapy for chronic type B hepatitis.

Authors:  Y Karino; T Sugawara; A Saga; J Yoshida; T Matsushima; T Miyazaki; J Toyota; Y Okuuchi
Journal:  Gastroenterol Jpn       Date:  1989-04

3.  The role of the immune system in establishment of herpes simplex virus latency--studies using CD4+ T-cell depleted mice.

Authors:  D S Schmidt; A M Eis-Hübinger; K E Schneweis
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  5'-O-Monophosphoryladenylyl(2' goes to 5')adenylyl(2' goes to 5')adenosine is an antagonist of the action of 5'-O-triphosphoryladenylyl-(2' goes to 5')adenylyl(2' goes to 5')adenosine and double-stranded RNA.

Authors:  P F Torrence; J Imai; M I Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

5.  Detection of elevated levels of 2-5A synthetase in serum from children with various infectious diseases.

Authors:  H Sugino; I Mitani; M Koike; T Kodama; J Sokawa; H Sawai; K Ishibashi; M Itoh; S Watanabe; Y Sokawa
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

6.  (2'-5') Oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections.

Authors:  A Schattner; G Merlin; V Bregman; T Hahn; S Levin; M Revel; D Wallach
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

7.  Interferon-induced 2-5A synthetase activity in human peripheral blood mononuclear cells after immunization with influenza virus and rubella virus vaccines.

Authors:  L J Penn; B R Williams
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

8.  2',5'-Oligoadenylate synthetase activity in the liver and peripheral blood mononuclear cells of chronic hepatitis patients.

Authors:  Y Ogawa
Journal:  Gastroenterol Jpn       Date:  1988-06

9.  The ESCRT-Related ATPase Vps4 Is Modulated by Interferon during Herpes Simplex Virus 1 Infection.

Authors:  Jorge Ruben Cabrera; Richard Manivanh; Brian J North; David A Leib
Journal:  mBio       Date:  2019-03-05       Impact factor: 7.786

10.  Alteration of intracerebral cytokine production in mice infected with herpes simplex virus types 1 and 2.

Authors:  G Lewandowski; M V Hobbs; F E Bloom
Journal:  J Neuroimmunol       Date:  1994-11       Impact factor: 3.478

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.